Cargando…

Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy

BACKGROUND: The etiology of dilated cardiomyopathy (DCM) is unclear. Bioinformatics algorithms may help to explore the underlying mechanisms. Therefore, we aimed to screen diagnostic biomarkers and identify the landscape of immune infiltration in DCM. METHODS: First, the CIBERSORT algorithm was used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qingquan, Fan, Mengkang, Cao, Xueyan, Geng, Haihua, Su, Yamin, Wu, Chunyu, Pan, Haiyan, Pan, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010553/ https://www.ncbi.nlm.nih.gov/pubmed/35433865 http://dx.doi.org/10.3389/fcvm.2022.809470

Ejemplares similares

Identification of Heparan Sulfate in Dilated Cardiomyopathy by Integrated Bioinformatics Analysis
por: Song, Wenyu, et al.
Publicado: (2022)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Exploring the pathogenesis and immune infiltration in dilated cardiomyopathy complicated with atrial fibrillation by bioinformatics analysis
por: Gan, Ting, et al.
Publicado: (2023)

Alterated gene expression in dilated cardiomyopathy after left ventricular assist device support by bioinformatics analysis
por: Wei, Ying, et al.
Publicado: (2023)

Genotype‐specific pathogenic effects in human dilated cardiomyopathy
por: Bollen, Ilse A. E., et al.
Publicado: (2017)

Bioinformatics and Immune Infiltration Analyses Reveal the Key Pathway and Immune Cells in the Pathogenesis of Hypertrophic Cardiomyopathy
por: Zhang, Xu-Zhe, et al.
Publicado: (2021)

Robust Rank Aggregation and Least Absolute Shrinkage and Selection Operator Analysis of Novel Gene Signatures in Dilated Cardiomyopathy
por: Ma, Xiao, et al.
Publicado: (2021)

A multifactorial aetiology for dilated cardiomyopathy
por: Herrera Flores, Cristian, et al.
Publicado: (2021)

Exploring Key Genes to Construct a Diagnosis Model of Dilated Cardiomyopathy
por: Zheng, Youyang, et al.
Publicado: (2022)

Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy
por: Yang, Yujiao, et al.
Publicado: (2022)

Corrigendum: Robust rank aggregation and least absolute shrinkage and selection operator analysis of novel gene signatures in dilated cardiomyopathy
por: Ma, Xiao, et al.
Publicado: (2022)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

The Genetic Pathways Underlying Immunotherapy in Dilated Cardiomyopathy
por: Kadhi, Ayat, et al.
Publicado: (2021)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Integrative bioinformatics analysis to explore a robust diagnostic signature and landscape of immune cell infiltration in sarcoidosis
por: Duo, Mengjie, et al.
Publicado: (2022)

Sex and gender differences in myocarditis and dilated cardiomyopathy: An update
por: Fairweather, DeLisa, et al.
Publicado: (2023)

Phosphoproteomic Analysis Reveals Downstream PKA Effectors of AKAP Cypher/ZASP in the Pathogenesis of Dilated Cardiomyopathy
por: Lv, Jialan, et al.
Publicado: (2021)

Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis
por: Wang, Zuoxiang, et al.
Publicado: (2022)

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction
por: Chen, Yanjia, et al.
Publicado: (2021)

Changes in the Left Ventricular Eicosanoid Profile in Human Dilated Cardiomyopathy
por: Sosnowski, Deanna K., et al.
Publicado: (2022)

DILATED CARDIOMYOPATHY WITH CARDIOGENIC SHOCK SECONDARY TO COVID-19 INFECTION
por: RICHARDSON, AUSTIN, et al.
Publicado: (2022)

Identification of immune-related hub genes and miRNA-mRNA pairs involved in immune infiltration in human septic cardiomyopathy by bioinformatics analysis
por: Li, Jingru, et al.
Publicado: (2022)

Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
por: Vignoli, Alessia, et al.
Publicado: (2022)

Early-stage alcohol-induced cardiomyopathy: not so much dilatation and dysfunction
por: Carrillo-Bailen, Magdalena, et al.
Publicado: (2023)

Development and validation of nomogram for unplanned ICU admission in patients with dilated cardiomyopathy
por: Li, Xiao-Lei, et al.
Publicado: (2023)

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance
por: Izquierdo, Cristian, et al.
Publicado: (2021)

WGCNA combined with machine learning algorithms for analyzing key genes and immune cell infiltration in heart failure due to ischemic cardiomyopathy
por: Kong, XiangJin, et al.
Publicado: (2023)

Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy
por: Xu, Man, et al.
Publicado: (2022)

Multiple-model machine learning identifies potential functional genes in dilated cardiomyopathy
por: Zhang, Lin, et al.
Publicado: (2023)

Giant right atrium in a child with dilated cardiomyopathy: A case report
por: Wang, Benzhen, et al.
Publicado: (2023)

Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis
por: Peng, Cheng, et al.
Publicado: (2023)

Bioinformatics prediction of potential mechanisms and biomarkers underlying dilated cardiomyopathy
por: Liu, Zhou, et al.
Publicado: (2022)

Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance
por: Mitropoulou, Panagiota, et al.
Publicado: (2020)

Association Between Left Ventricular Global Function Index and Outcomes in Patients With Dilated Cardiomyopathy
por: Liu, Tong, et al.
Publicado: (2021)

The Potential of Metabolism-Related Gene OGDHL as a Biomarker for Myocardial Remodeling in Dilated Cardiomyopathy
por: Tang, Yaohan, et al.
Publicado: (2022)

Elevated α-hydroxybutyrate dehydrogenase is associated with in-hospital mortality in non-ischemic dilated cardiomyopathy
por: Li, Xinyi, et al.
Publicado: (2022)

Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy
por: Portokallidou, Konstantina, et al.
Publicado: (2023)

Electrocardiographic characteristics associated with late gadolinium enhancement and prognostic value in patients with dilated cardiomyopathy
por: Chayanopparat, Punyanuch, et al.
Publicado: (2023)

Identification and validation of ferroptosis-related genes and immune infiltration in ischemic cardiomyopathy
por: Huang, Kai, et al.
Publicado: (2023)

Vanishing Left Ventricular Thrombi in Severe Aortic Stenosis with Dilated Cardiomyopathy
por: Kharwar, Rajiv Bharat, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6gtg468r28ev9vlnc4mhjft8eq